Lehman Raises D&K Healthcare to 'Strong Buy'

Analyst Lawrence Marsh sees continued expansion in growth rates, and a broadening customer base for the drug and healthcare products distributor

Lehman Brothers upgraded D&K Healthcare (DKWD ) to strong buy from buy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.